Jizhou Wu
About
Jizhou Wu studied Pharmaceutical Engineering at China Pharmaceutical University, China, from 2018 to 2022, earning his Bachelor's degree in 2022. In 2025, he obtained his Master's degree in Microbial and Biochemical Pharmacy from the Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, China. From February to October 2026, he conducted his Master's research at Saarland University, Germany, under the supervision of Prof. Dr. Anna K. H. Hirsch, where he obtained his Master of Science (M.Sc.) degree in Pharmacy.
During his academic training, he gained research experience in the total synthesis of nucleoside-peptide natural products, the structure optimization of PBTZ169-related antitubercular agents, and the synthesis and structural modification of the peptide natural product corramycin.
Since November 2026, he has been a PhD-student in the Department of Drug Design and Optimization at HIPS, under the supervision of Prof. Dr. Anna K. H. Hirsch. His research focuses on the structural optimization of the natural product corramycin and the discovery of novel chemical scaffolds targeting the corramycin target protein through structure-based virtual screening and docking.